Features

Led by inhaler device platform designer and supplier Merxin and by Nanopharm, a CRO specializing in inhaled and nasal drugs, a group of companies that offer products and services for OINDP development has come together… Read more . . .

Over 500 OINDP specialists attended RDD Europe 2019 in Estoril, Portugal, May 7-10, making the conference the biggest RDD Europe meeting ever, the organizers said. Carolyn Penot of Aptar Pharma, which co-organizes RDD Europe said,… Read more . . .

What is dynamic powder testing and why is it valuable for DPI development? Read more . . .

RDD Europe 2019 will take place May 7-10 at the Estoril Congress Center outside of Lisbon. Organizers expect approximately 500 inhaled and nasal drug specialists from industry, academia, and regulatory agencies to attend this year’s… Read more . . .

One of the distinguishing features of RDD Europe is the workshop session, when a dozen companies offer 60-minute presentations on their latest technology, products, or services to small groups of 10-40 people at a time.… Read more . . .

The annual Drug Delivery to the Lungs meeting once again experienced significant growth in attendance and sponsorship, as DDL 2018 drew more than 850 attendees and 110 exhibitors to the Edinburg International Conference Centre. Many… Read more . . .

Organizers of DDL 2018 say that they are expecting over 800 OINDP specialists to attend this year’s iteration of the Drug Delivery to the Lungs meeting, to be held December 12-14 in Edinburgh, UK. According… Read more . . .

Approximately 550 OINDP specialists attended RDD 2018 in Tucson, Arizona, where much of the interest centered around regulatory issues, especially in light of the FDA’s recent release of a revised draft guidance on MDI and… Read more . . .

Copley Scientific CEO Mark Copley discusses the recently published USP Chapter <1602> for testing “Spacers & Valved Holding Chambers Used with Inhalation Aerosols” Q: What does this new USP Chapter cover? A: Chapter <1602>, published… Read more . . .